 Randall Wilkening
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 65 | 2023 | 764 | 1.360 |
Why?
| | Placenta | 38 | 2023 | 639 | 1.310 |
Why?
| | Fetus | 34 | 2023 | 690 | 1.200 |
Why?
| | Fetal Growth Retardation | 17 | 2023 | 468 | 0.870 |
Why?
| | Uterus | 18 | 2020 | 194 | 0.710 |
Why?
| | Amino Acids | 12 | 2023 | 465 | 0.650 |
Why?
| | Maternal-Fetal Exchange | 17 | 2013 | 157 | 0.620 |
Why?
| | Oxygen Consumption | 15 | 2004 | 586 | 0.610 |
Why?
| | Oxygen | 16 | 2023 | 854 | 0.570 |
Why?
| | Liver | 14 | 2020 | 1816 | 0.560 |
Why?
| | Placental Insufficiency | 7 | 2023 | 104 | 0.530 |
Why?
| | Pregnancy | 58 | 2023 | 5691 | 0.500 |
Why?
| | Fetal Blood | 18 | 2014 | 272 | 0.470 |
Why?
| | Fetal Hypoxia | 4 | 2017 | 46 | 0.440 |
Why?
| | Glucose | 14 | 2023 | 953 | 0.400 |
Why?
| | Pregnancy, Animal | 7 | 2006 | 57 | 0.400 |
Why?
| | Umbilical Cord | 10 | 2016 | 84 | 0.360 |
Why?
| | Hindlimb | 6 | 2017 | 137 | 0.350 |
Why?
| | Umbilical Arteries | 7 | 2005 | 38 | 0.330 |
Why?
| | Animals | 69 | 2023 | 33381 | 0.280 |
Why?
| | Pulmonary Circulation | 7 | 1991 | 424 | 0.270 |
Why?
| | Regional Blood Flow | 17 | 2005 | 418 | 0.270 |
Why?
| | Acidosis | 2 | 2020 | 86 | 0.250 |
Why?
| | Hypoxia | 4 | 2016 | 963 | 0.240 |
Why?
| | Umbilical Veins | 9 | 2001 | 59 | 0.240 |
Why?
| | RNA, Messenger | 5 | 2016 | 2657 | 0.210 |
Why?
| | Ethanol | 6 | 2004 | 575 | 0.190 |
Why?
| | Blood Glucose | 12 | 2014 | 1939 | 0.190 |
Why?
| | Organ Size | 12 | 2016 | 460 | 0.190 |
Why?
| | Chorioamnionitis | 1 | 2020 | 37 | 0.180 |
Why?
| | Protein Biosynthesis | 2 | 2017 | 397 | 0.180 |
Why?
| | Female | 64 | 2023 | 61565 | 0.180 |
Why?
| | Gestational Age | 13 | 2006 | 765 | 0.180 |
Why?
| | Insulin | 8 | 2017 | 2162 | 0.180 |
Why?
| | Lactates | 6 | 1993 | 87 | 0.170 |
Why?
| | Glucagon | 2 | 2016 | 97 | 0.170 |
Why?
| | Biological Transport | 10 | 2014 | 382 | 0.170 |
Why?
| | Glutamic Acid | 6 | 2014 | 224 | 0.160 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.160 |
Why?
| | Gluconeogenesis | 3 | 2014 | 66 | 0.160 |
Why?
| | Anemia | 2 | 2017 | 146 | 0.160 |
Why?
| | Vasodilation | 5 | 1991 | 457 | 0.160 |
Why?
| | Lactic Acid | 9 | 2023 | 282 | 0.160 |
Why?
| | Umbilicus | 3 | 2013 | 15 | 0.150 |
Why?
| | Carbohydrate Metabolism | 2 | 2010 | 50 | 0.150 |
Why?
| | Glutamine | 4 | 2023 | 88 | 0.140 |
Why?
| | Threonine | 3 | 2003 | 45 | 0.140 |
Why?
| | Disease Models, Animal | 6 | 2020 | 3730 | 0.140 |
Why?
| | Muscle Proteins | 1 | 2017 | 219 | 0.140 |
Why?
| | Muscle, Skeletal | 3 | 2017 | 1515 | 0.130 |
Why?
| | Dexamethasone | 4 | 2003 | 320 | 0.130 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 32 | 0.130 |
Why?
| | Blood Flow Velocity | 6 | 1999 | 327 | 0.130 |
Why?
| | Respiratory Therapy | 1 | 1993 | 19 | 0.120 |
Why?
| | Glycine | 3 | 2023 | 162 | 0.120 |
Why?
| | Antipyrine | 2 | 1984 | 3 | 0.120 |
Why?
| | Leucine | 3 | 2001 | 117 | 0.110 |
Why?
| | Pancuronium | 2 | 1990 | 4 | 0.110 |
Why?
| | Macrophages | 1 | 2020 | 1324 | 0.110 |
Why?
| | Hyperinsulinism | 1 | 1994 | 107 | 0.110 |
Why?
| | Histamine | 2 | 1990 | 65 | 0.110 |
Why?
| | Hydrocortisone | 4 | 2020 | 273 | 0.110 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2012 | 26 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1993 | 101 | 0.110 |
Why?
| | Streptococcus agalactiae | 1 | 1993 | 88 | 0.110 |
Why?
| | Swimming | 1 | 2012 | 46 | 0.110 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1993 | 132 | 0.110 |
Why?
| | Estrogen Receptor beta | 1 | 2012 | 37 | 0.110 |
Why?
| | Tryptophan Hydroxylase | 1 | 2012 | 52 | 0.110 |
Why?
| | Raphe Nuclei | 1 | 2012 | 118 | 0.100 |
Why?
| | Streptococcal Infections | 1 | 1993 | 141 | 0.100 |
Why?
| | Acid-Base Equilibrium | 3 | 2003 | 29 | 0.100 |
Why?
| | Up-Regulation | 1 | 2014 | 872 | 0.100 |
Why?
| | Hot Temperature | 5 | 2001 | 334 | 0.100 |
Why?
| | Antidepressive Agents | 1 | 2012 | 189 | 0.100 |
Why?
| | Islets of Langerhans | 1 | 2017 | 739 | 0.090 |
Why?
| | Lysine | 2 | 2003 | 248 | 0.090 |
Why?
| | Receptors, Histamine H1 | 1 | 1990 | 4 | 0.090 |
Why?
| | Carbohydrates | 1 | 2010 | 59 | 0.090 |
Why?
| | Receptors, Histamine H2 | 1 | 1990 | 10 | 0.090 |
Why?
| | Hypoglycemia | 1 | 2014 | 400 | 0.090 |
Why?
| | Glycogen | 2 | 2016 | 59 | 0.090 |
Why?
| | Serine | 2 | 2023 | 138 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2566 | 0.090 |
Why?
| | Neuromuscular Junction | 1 | 1989 | 53 | 0.090 |
Why?
| | Diffusion | 4 | 1991 | 122 | 0.090 |
Why?
| | Nerve Block | 1 | 1989 | 67 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 1992 | 502 | 0.080 |
Why?
| | Alanine | 3 | 2000 | 102 | 0.080 |
Why?
| | Hemoglobin A | 1 | 1988 | 22 | 0.080 |
Why?
| | Oxyhemoglobins | 1 | 1988 | 22 | 0.080 |
Why?
| | Nitric Oxide | 1 | 1993 | 892 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 774 | 0.080 |
Why?
| | Pelvis | 1 | 1988 | 92 | 0.080 |
Why?
| | Hemodynamics | 3 | 1991 | 1004 | 0.080 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2006 | 287 | 0.070 |
Why?
| | Osmolar Concentration | 5 | 2004 | 185 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2006 | 22 | 0.070 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 24 | 0.070 |
Why?
| | Receptor, TIE-2 | 1 | 2005 | 12 | 0.070 |
Why?
| | Angiopoietin-1 | 1 | 2005 | 10 | 0.070 |
Why?
| | Angiopoietin-2 | 1 | 2005 | 13 | 0.070 |
Why?
| | Glucocorticoids | 3 | 2001 | 545 | 0.070 |
Why?
| | Polymers | 1 | 2010 | 482 | 0.070 |
Why?
| | Hemoglobins | 1 | 1988 | 326 | 0.070 |
Why?
| | Vasodilator Agents | 1 | 1988 | 328 | 0.070 |
Why?
| | Microspheres | 3 | 1991 | 130 | 0.070 |
Why?
| | Pulmonary Artery | 2 | 1988 | 1063 | 0.070 |
Why?
| | Placental Circulation | 2 | 2006 | 56 | 0.070 |
Why?
| | Models, Biological | 6 | 2005 | 1715 | 0.060 |
Why?
| | Cycloleucine | 1 | 2004 | 3 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| | Glutamate Dehydrogenase | 1 | 2003 | 3 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 527 | 0.060 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 103 | 0.060 |
Why?
| | Blood Pressure | 6 | 2005 | 1664 | 0.060 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2002 | 50 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 55 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 122 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 178 | 0.050 |
Why?
| | Isoleucine | 1 | 2001 | 12 | 0.050 |
Why?
| | Liver Circulation | 2 | 2000 | 23 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 367 | 0.050 |
Why?
| | Labor, Induced | 2 | 2001 | 30 | 0.050 |
Why?
| | Histidine | 1 | 2001 | 63 | 0.050 |
Why?
| | Infant Care | 1 | 1981 | 43 | 0.050 |
Why?
| | Valine | 1 | 2001 | 77 | 0.050 |
Why?
| | Labor, Obstetric | 1 | 2001 | 53 | 0.050 |
Why?
| | Phenylalanine | 1 | 2001 | 66 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1993 | 536 | 0.050 |
Why?
| | Lung | 3 | 1988 | 3664 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 225 | 0.050 |
Why?
| | Methionine | 1 | 2001 | 145 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 125 | 0.050 |
Why?
| | Tryptophan | 1 | 2001 | 139 | 0.050 |
Why?
| | Placental Hormones | 1 | 1999 | 5 | 0.050 |
Why?
| | Indocyanine Green | 1 | 1999 | 13 | 0.040 |
Why?
| | Norepinephrine | 1 | 2020 | 212 | 0.040 |
Why?
| | Partial Pressure | 3 | 2006 | 29 | 0.040 |
Why?
| | Coloring Agents | 1 | 1999 | 73 | 0.040 |
Why?
| | Veins | 2 | 1991 | 60 | 0.040 |
Why?
| | Infusions, Intravenous | 3 | 2003 | 380 | 0.040 |
Why?
| | Carbon Dioxide | 4 | 1997 | 230 | 0.040 |
Why?
| | Carbon Radioisotopes | 2 | 2014 | 45 | 0.040 |
Why?
| | Body Temperature | 3 | 2006 | 215 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2020 | 870 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2012 | 1945 | 0.040 |
Why?
| | Glucose-6-Phosphatase | 1 | 2016 | 32 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 982 | 0.030 |
Why?
| | Hypertension | 1 | 2005 | 1203 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 938 | 0.030 |
Why?
| | Kinetics | 3 | 1996 | 1624 | 0.030 |
Why?
| | Infant, Newborn | 4 | 1995 | 5255 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 205 | 0.030 |
Why?
| | Sheep, Domestic | 1 | 2014 | 32 | 0.030 |
Why?
| | Arteries | 2 | 1999 | 250 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 745 | 0.030 |
Why?
| | Glutamates | 1 | 1994 | 60 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 627 | 0.030 |
Why?
| | DNA, Complementary | 2 | 2005 | 268 | 0.030 |
Why?
| | Embryonic and Fetal Development | 3 | 2001 | 95 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1691 | 0.030 |
Why?
| | Bicarbonates | 1 | 1993 | 44 | 0.030 |
Why?
| | Humans | 11 | 2023 | 118974 | 0.030 |
Why?
| | Body Weight | 2 | 1997 | 934 | 0.030 |
Why?
| | Time Factors | 2 | 1993 | 6412 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2012 | 311 | 0.030 |
Why?
| | Guinea Pigs | 1 | 1992 | 151 | 0.030 |
Why?
| | Blood-Brain Barrier | 1 | 2012 | 108 | 0.030 |
Why?
| | Cats | 1 | 1992 | 205 | 0.030 |
Why?
| | Horses | 1 | 1992 | 106 | 0.030 |
Why?
| | Constriction | 1 | 1991 | 46 | 0.030 |
Why?
| | Plasmids | 1 | 2012 | 355 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2012 | 126 | 0.020 |
Why?
| | Neurogenesis | 1 | 2012 | 105 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 134 | 0.020 |
Why?
| | Biological Transport, Active | 2 | 2005 | 73 | 0.020 |
Why?
| | Heart Rate | 3 | 1990 | 729 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 1991 | 95 | 0.020 |
Why?
| | Myo-Inositol-1-Phosphate Synthase | 1 | 2010 | 2 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1636 | 0.020 |
Why?
| | Fever | 2 | 2003 | 283 | 0.020 |
Why?
| | Mannose | 1 | 2010 | 21 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2445 | 0.020 |
Why?
| | Inositol | 1 | 2010 | 26 | 0.020 |
Why?
| | Sorbitol | 1 | 2010 | 27 | 0.020 |
Why?
| | Rabbits | 1 | 1992 | 780 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 348 | 0.020 |
Why?
| | Vascular Resistance | 2 | 1988 | 356 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 325 | 0.020 |
Why?
| | Histamine H1 Antagonists | 1 | 1990 | 33 | 0.020 |
Why?
| | Histamine H2 Antagonists | 1 | 1990 | 31 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 1993 | 545 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 29 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2009 | 32 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.020 |
Why?
| | Mathematics | 2 | 1996 | 103 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 1989 | 40 | 0.020 |
Why?
| | Fructose | 1 | 2010 | 204 | 0.020 |
Why?
| | Iliac Vein | 1 | 1988 | 9 | 0.020 |
Why?
| | Iliac Artery | 1 | 1988 | 44 | 0.020 |
Why?
| | Bradykinin | 1 | 1988 | 48 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 735 | 0.020 |
Why?
| | Algorithms | 1 | 2014 | 1541 | 0.020 |
Why?
| | Acetylcholine | 1 | 1988 | 208 | 0.020 |
Why?
| | Tolazoline | 1 | 1986 | 3 | 0.020 |
Why?
| | Muscles | 1 | 1988 | 333 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2478 | 0.020 |
Why?
| | Heating | 1 | 2006 | 18 | 0.020 |
Why?
| | Placentation | 1 | 2005 | 43 | 0.020 |
Why?
| | Respiration | 1 | 2006 | 183 | 0.020 |
Why?
| | DNA | 1 | 2012 | 1388 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 2851 | 0.020 |
Why?
| | Bone and Bones | 1 | 1988 | 289 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2005 | 33 | 0.020 |
Why?
| | Pulsatile Flow | 1 | 2005 | 54 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2275 | 0.020 |
Why?
| | Decarboxylation | 2 | 1994 | 3 | 0.020 |
Why?
| | 2-Aminoadipic Acid | 1 | 2003 | 7 | 0.020 |
Why?
| | Amino Acids, Essential | 1 | 2003 | 12 | 0.020 |
Why?
| | Length of Stay | 1 | 1989 | 1032 | 0.010 |
Why?
| | Signal Transduction | 2 | 2009 | 4709 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 2003 | 113 | 0.010 |
Why?
| | Nuclease Protection Assays | 1 | 2003 | 5 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5392 | 0.010 |
Why?
| | Skin | 1 | 1988 | 657 | 0.010 |
Why?
| | Drinking | 1 | 2003 | 36 | 0.010 |
Why?
| | Oxidation-Reduction | 2 | 1983 | 940 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2003 | 194 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 67 | 0.010 |
Why?
| | Respiratory Mechanics | 1 | 2003 | 60 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2003 | 94 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Male | 3 | 2017 | 57801 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 67 | 0.010 |
Why?
| | Birth Weight | 2 | 1999 | 465 | 0.010 |
Why?
| | Species Specificity | 1 | 2002 | 565 | 0.010 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2001 | 198 | 0.010 |
Why?
| | Homeostasis | 1 | 1984 | 594 | 0.010 |
Why?
| | Fetal Weight | 1 | 2000 | 51 | 0.010 |
Why?
| | Carbon Isotopes | 1 | 2000 | 115 | 0.010 |
Why?
| | Placental Lactogen | 1 | 1999 | 20 | 0.010 |
Why?
| | Prolactin | 1 | 1999 | 96 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 1981 | 131 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2159 | 0.010 |
Why?
| | Prenatal Care | 1 | 1981 | 252 | 0.010 |
Why?
| | Blotting, Western | 1 | 2001 | 1194 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 242 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2871 | 0.010 |
Why?
| | Trophoblasts | 1 | 1999 | 170 | 0.010 |
Why?
| | Phentolamine | 2 | 1987 | 17 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 81 | 0.010 |
Why?
| | Keto Acids | 1 | 1996 | 13 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2002 | 1055 | 0.010 |
Why?
| | Linear Models | 1 | 1997 | 827 | 0.010 |
Why?
| | Regression Analysis | 1 | 1996 | 983 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1995 | 806 | 0.010 |
Why?
| | Meclofenamic Acid | 1 | 1991 | 4 | 0.010 |
Why?
| | Phospholipid Ethers | 1 | 1991 | 7 | 0.010 |
Why?
| | Medical Indigency | 1 | 1989 | 10 | 0.010 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 1987 | 31 | 0.000 |
Why?
| | Infant, Newborn, Diseases | 1 | 1989 | 106 | 0.000 |
Why?
| | Perfusion | 1 | 1987 | 153 | 0.000 |
Why?
| | Cimetidine | 1 | 1986 | 16 | 0.000 |
Why?
| | Humidity | 1 | 1987 | 45 | 0.000 |
Why?
| | Verapamil | 1 | 1986 | 32 | 0.000 |
Why?
| | Diphenhydramine | 1 | 1986 | 29 | 0.000 |
Why?
| | Fetal Heart | 1 | 1986 | 29 | 0.000 |
Why?
| | Adult | 2 | 2002 | 31512 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1989 | 482 | 0.000 |
Why?
| | Tritium | 1 | 1983 | 70 | 0.000 |
Why?
| | Patient Readmission | 1 | 1989 | 634 | 0.000 |
Why?
| | Organ Specificity | 1 | 1983 | 278 | 0.000 |
Why?
| | Patient Discharge | 1 | 1989 | 796 | 0.000 |
Why?
| | Fasting | 1 | 1983 | 264 | 0.000 |
Why?
|
|
Wilkening's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|